Cofoe Medical Sets 28 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results and Dividend Proposal

Bulletin Express

08/14

Cofoe Medical Technology Co., Ltd. announced that its board of directors will convene on 28 August 2026 to review and approve the unaudited interim results of the Company and its subsidiaries for the six-month period ended 30 June 2026. The agenda also includes considering a potential interim dividend recommendation and addressing other business matters.

The board currently comprises four executive directors—Zhang Min (Chairman), Zhang Zhiming, Xue Xiaoqiao and He Bangjie—and three independent non-executive directors—Ning Huabo, Shen Nan and Zhou Rong.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/news/1176343321"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1176343321\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1176343321?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-14 16:47","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176343321","market":"us","top_or_hot":-1,"title":"Cofoe Medical Sets 28 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results and Dividend Proposal","media":"Bulletin Express","content":"<p>Cofoe Medical Technology Co., Ltd. announced that its board of directors will convene on 28 August 2026 to review and approve the unaudited interim results of the Company and its subsidiaries for the six-month period ended 30 June 2026. The agenda also includes considering a potential interim dividend recommendation and addressing other business matters.</p>\n<p>The board currently comprises four executive directors—Zhang Min (Chairman), Zhang Zhiming, Xue Xiaoqiao and He Bangjie—and three independent non-executive directors—Ning Huabo, Shen Nan and Zhou Rong.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cofoe Medical Sets 28 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results and Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCofoe Medical Sets 28 Aug 2026 Board Meeting to Approve 1H 2026 Interim Results and Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-14 16:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Cofoe Medical Technology Co., Ltd. announced that its board of directors will convene on 28 August 2026 to review and approve the unaudited interim results of the Company and its subsidiaries for the six-month period ended 30 June 2026. The agenda also includes considering a potential interim dividend recommendation and addressing other business matters.</p>\n<p>The board currently comprises four executive directors—Zhang Min (Chairman), Zhang Zhiming, Xue Xiaoqiao and He Bangjie—and three independent non-executive directors—Ning Huabo, Shen Nan and Zhou Rong.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01187","symbol_name":"可孚医疗","start_time":0,"source_url":"","article_id":"1176343321","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176343321","pubTimestamp":1786697265,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Cofoe Medical Technology Co., Ltd. announced that its board of directors will convene on 28 August 2026 to review and approve the unaudited interim results of the Company and its subsidiaries for the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01187":"可孚医疗"},"translate_title":"Cofoe Medical Sets 2026 年 8 月 28 日董事会会议批准 2026 年上半年中期业绩和股息提案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01187":1},"content_text":"Cofoe Medical Technology Co., Ltd. announced that its board of directors will convene on 28 August 2026 to review and approve the unaudited interim results of the Company and its subsidiaries for the six-month period ended 30 June 2026. The agenda also includes considering a potential interim dividend recommendation and addressing other business matters.\nThe board currently comprises four executive directors—Zhang Min (Chairman), Zhang Zhiming, Xue Xiaoqiao and He Bangjie—and three independent non-executive directors—Ning Huabo, Shen Nan and Zhou Rong.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}